Overview

Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This study is the first to try this product in the rectum of humans. This study is only to find out if the gel is safe for use in the rectum, not to see if the gel works. Information gathered from this study will help investigators decide whether this gel is safe enough to move onto the next phase of studies. Information gathered from this study will also help investigators determine what participants did and did not like about the product and what types of products people might want to use in the future. Currently condoms and abstinence are the only methods proven to prevent the spread of HIV sexually.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, Los Angeles
Collaborators:
CONRAD
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Anti-Infective Agents
UC-781